Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Gut microbes · 2026
Article
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Jerry Elorm AkresiDepartment of Food Science and Technology, Nebraska Food for Health Center, University of Nebraska - Lincoln, Lincoln, NE, USA.
Thi Van Thanh DoDepartment of Food Science and Technology, Nebraska Food for Health Center, University of Nebraska - Lincoln, Lincoln, NE, USA.
Zhisong CuiDepartment of Food Science and Technology, Nebraska Food for Health Center, University of Nebraska - Lincoln, Lincoln, NE, USA.
N R Siva ShanmugamDepartment of Food Science and Technology, Nebraska Food for Health Center, University of Nebraska - Lincoln, Lincoln, NE, USA.
Sarah MoraïsDepartment of Life Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Itzhak MizrahiDepartment of Life Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.ORCID 0000-0001-6636-8818
Edward A BayerDepartment of Life Sciences, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Jennifer M AuchtungDepartment of Food Science and Technology, Nebraska Food for Health Center, University of Nebraska - Lincoln, Lincoln, NE, USA.
Yanbin YinDepartment of Food Science and Technology, Nebraska Food for Health Center, University of Nebraska - Lincoln, Lincoln, NE, USA.ORCID 0000-0001-7667-881X
Funding
Exploration of cloud computing for CAZyme researchR01GM140370 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI YIN, YANBIN · 2021 to 2024
$1.5M
Glycan Utilization Profiling in Human Gut Microbiomes of Common Funds DataR03OD039979 · OD · UNIVERSITY OF NEBRASKA LINCOLN · PI YIN, YANBIN · 2025 to 2025
$294k
NIGMS NIH HHS R01 GM140370NIH HHS R03 OD039979
6 · The paper itself
Abstract
Mucins create a physical barrier that protects human and animal tissues from microbial pathogens. Here, we provide evidence that mucin degradation can be mediated by unique mucinolysomes, defined as extracellular cellulosome-like multi-enzyme complexes specializing in mucin degradation. We predicted the presence of mucinolysomes across 63 metagenome-assembled genomes (MAGs) and two isolated genomes of three anaerobic species
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.